Theodore C. Jessop, Ph.D. - Publications

2005 Stanford University, Palo Alto, CA 
Organic, Organometallic, Bioorganic, and Medicinal Chemistry

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Salojin KV, Hamman BD, Chang WC, Jhaver KG, Al-Shami A, Crisostomo J, Wilkins C, Digeorge-Foushee AM, Allen J, Patel N, Gopinathan S, Zhou J, Nouraldeen A, Jessop TC, Bagdanoff JT, et al. Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. Plos One. 9: e98151. PMID 24852423 DOI: 10.1371/journal.pone.0098151  0.88
2010 Bagdanoff JT, Donoviel MS, Nouraldeen A, Carlsen M, Jessop TC, Tarver J, Aleem S, Dong L, Zhang H, Boteju L, Hazelwood J, Yan J, Bednarz M, Layek S, Owusu IB, et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). Journal of Medicinal Chemistry. 53: 8650-62. PMID 21090716 DOI: 10.1021/jm101183p  0.88
2009 Jessop TC, Tarver JE, Carlsen M, Xu A, Healy JP, Heim-Riether A, Fu Q, Taylor JA, Augeri DJ, Shen M, Stouch TR, Swanson RV, Tari LW, Hunter M, Hoffman I, et al. Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 6784-7. PMID 19836232 DOI: 10.1016/j.bmcl.2009.09.081  0.88
2009 Tarver JE, Jessop TC, Carlsen M, Augeri DJ, Fu Q, Healy JP, Heim-Riether A, Xu A, Taylor JA, Shen M, Keyes PE, David Kimball S, Yu XC, Miranda M, Liu Q, et al. 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase. Bioorganic & Medicinal Chemistry Letters. 19: 6780-3. PMID 19836229 DOI: 10.1016/j.bmcl.2009.09.082  0.88
2009 Bagdanoff JT, Donoviel MS, Nouraldeen A, Tarver J, Fu Q, Carlsen M, Jessop TC, Zhang H, Hazelwood J, Nguyen H, Baugh SD, Gardyan M, Terranova KM, Barbosa J, Yan J, et al. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. Journal of Medicinal Chemistry. 52: 3941-53. PMID 19489538 DOI: 10.1021/jm900278w  0.88
2006 Rothbard JB, Jessop TC, Wender PA. Molecular understanding of cellular uptake by arginine-rich cell penetrating peptides Acs Symposium Series. 923: 166-181.  0.88
2005 Rothbard JB, Jessop TC, Wender PA. Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Advanced Drug Delivery Reviews. 57: 495-504. PMID 15722160 DOI: 10.1016/j.addr.2004.10.003  0.88
2004 Rothbard JB, Jessop TC, Lewis RS, Murray BA, Wender PA. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. Journal of the American Chemical Society. 126: 9506-7. PMID 15291531 DOI: 10.1021/ja0482536  0.88
2004 Shi Kam NW, Jessop TC, Wender PA, Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells. Journal of the American Chemical Society. 126: 6850-1. PMID 15174838 DOI: 10.1021/ja0486059  0.88
2003 Wender PA, Baryza JL, Brenner SE, Clarke MO, Gamber GG, Horan JC, Jessop TC, Kan C, Pattabiraman K, Williams TJ. Inspirations from nature. New reactions, therapeutic leads, and drug delivery systems Pure and Applied Chemistry. 75: 143-155.  0.88
2002 Wender PA, Rothbard JB, Jessop TC, Kreider EL, Wylie BL. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. Journal of the American Chemical Society. 124: 13382-3. PMID 12418880 DOI: 10.1021/ja0275109  0.88
2001 Wender PA, Jessop TC, Pattabiraman K, Pelkey ET, VanDeusen CL. An efficient, scalable synthesis of the molecular transporter octaarginine via a segment doubling strategy. Organic Letters. 3: 3229-32. PMID 11594801 DOI: 10.1021/ol0161108  0.88
Show low-probability matches.